Q4 2013 13F Holders as of 12/31/2013
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
105M
-
Number of holders
-
430
-
Total 13F shares, excl. options
-
75.8M
-
Shares change
-
-225K
-
Total reported value, excl. options
-
$20.9B
-
Value change
-
-$62.6M
-
Put/Call ratio
-
1.23
-
Number of buys
-
10
-
Number of sells
-
-7
-
Price
-
$275.24
Significant Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q4 2013
458 filings reported holding REGN - REGENERON PHARMACEUTICALS, INC. - COMMON STOCK as of Q4 2013.
REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) has 430 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 75.8M shares
of 105M outstanding shares and own 72.24% of the company stock.
Largest 10 shareholders include Capital World Investors (8.86M shares), FMR LLC (7.24M shares), PRICE T ROWE ASSOCIATES INC /MD/ (6M shares), WELLINGTON MANAGEMENT CO LLP (4.33M shares), VANGUARD GROUP INC (3.79M shares), SANDS CAPITAL MANAGEMENT, LLC (3.73M shares), State Street Corp (3.37M shares), Artisan Partners Limited Partnership (3.14M shares), BlackRock Institutional Trust Company, N.A. (2.08M shares), and JPMORGAN CHASE & CO (1.85M shares).
This table shows the top 430 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.